15.29
price down icon0.52%   -0.08
pre-market  プレマーケット:  15.29  
loading
前日終値:
$15.37
開ける:
$15.9
24時間の取引高:
2.75M
Relative Volume:
1.67
時価総額:
$1.36B
収益:
$-249.00K
当期純損益:
$-187.60M
株価収益率:
-6.116
EPS:
-2.5
ネットキャッシュフロー:
$-201.88M
1週間 パフォーマンス:
+7.75%
1か月 パフォーマンス:
+14.88%
6か月 パフォーマンス:
+261.47%
1年 パフォーマンス:
+228.11%
1日の値動き範囲:
Value
$15.10
$16.96
1週間の範囲:
Value
$13.99
$16.96
52週間の値動き範囲:
Value
$2.865
$16.96

Amylyx Pharmaceuticals Inc Stock (AMLX) Company Profile

Name
名前
Amylyx Pharmaceuticals Inc
Name
セクター
Healthcare (1139)
Name
電話
617-683-0917
Name
住所
43 THORNDIKE STREET, CAMBRIDGE
Name
職員
123
Name
Twitter
Name
次回の収益日
2025-03-04
Name
最新のSEC提出書
Name
AMLX's Discussions on Twitter

AMLX を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
AMLX
Amylyx Pharmaceuticals Inc
15.29 1.64B -249.00K -187.60M -201.88M -2.50
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
426.27 107.45B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
474.00 64.39B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
579.34 61.13B 14.21B 4.46B 3.56B 39.69
Biotechnology icon
ARGX
Argen X Se Adr
834.75 52.30B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
165.31 35.49B 398.11M -1.03B -868.57M -5.7032

Amylyx Pharmaceuticals Inc Stock (AMLX) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-07-10 再開されました Goldman Buy
2025-06-24 開始されました Guggenheim Buy
2025-06-17 開始されました Citigroup Buy
2025-05-30 開始されました TD Cowen Buy
2025-04-07 アップグレード Mizuho Neutral → Outperform
2024-11-18 アップグレード Robert W. Baird Neutral → Outperform
2024-10-23 アップグレード BofA Securities Neutral → Buy
2024-03-18 ダウングレード Mizuho Buy → Neutral
2024-03-11 ダウングレード Leerink Partners Outperform → Market Perform
2024-03-11 ダウングレード Robert W. Baird Outperform → Neutral
2024-03-08 ダウングレード Evercore ISI Outperform → In-line
2024-03-08 ダウングレード Goldman Buy → Neutral
2024-01-03 開始されました Robert W. Baird Outperform
2023-12-12 開始されました Deutsche Bank Buy
2023-07-24 アップグレード Goldman Neutral → Buy
2023-03-31 開始されました Mizuho Buy
2023-01-05 開始されました BofA Securities Buy
2022-05-25 開始されました Citigroup Buy
2022-04-01 ダウングレード Goldman Buy → Neutral
すべてを表示

Amylyx Pharmaceuticals Inc (AMLX) 最新ニュース

pulisher
Oct 21, 2025

Trend analysis for Amylyx Pharmaceuticals Inc. this weekJuly 2025 Weekly Recap & Low Risk High Reward Trade Ideas - newser.com

Oct 21, 2025
pulisher
Oct 21, 2025

Using economic indicators to assess Amylyx Pharmaceuticals Inc. potential2025 Volume Leaders & Daily Price Action Insights - newser.com

Oct 21, 2025
pulisher
Oct 21, 2025

Tools to monitor Amylyx Pharmaceuticals Inc. recovery probabilityMarket Rally & Smart Money Movement Tracker - newser.com

Oct 21, 2025
pulisher
Oct 21, 2025

Will Amylyx Pharmaceuticals Inc. price bounce be sustainableJuly 2025 Gainers & Community Supported Trade Ideas - newser.com

Oct 21, 2025
pulisher
Oct 21, 2025

Measuring Amylyx Pharmaceuticals Inc.’s beta against major indicesJuly 2025 Volume & Weekly Market Pulse Alerts - newser.com

Oct 21, 2025
pulisher
Oct 20, 2025

Published on: 2025-10-20 22:38:43 - newser.com

Oct 20, 2025
pulisher
Oct 20, 2025

What’s the recovery path for long term holders of Amylyx Pharmaceuticals Inc.2025 Market Overview & Weekly High Potential Stock Alerts - newser.com

Oct 20, 2025
pulisher
Oct 20, 2025

Important Notice to Long-Term Shareholders of Amylyx - GlobeNewswire

Oct 20, 2025
pulisher
Oct 20, 2025

Will Amylyx Pharmaceuticals Inc. stock deliver better than expected guidanceWeekly Trade Analysis & Consistent Income Trade Recommendations - newser.com

Oct 20, 2025
pulisher
Oct 20, 2025

Using flow based indicators on Amylyx Pharmaceuticals Inc.Trade Analysis Report & Risk Managed Trade Strategies - newser.com

Oct 20, 2025
pulisher
Oct 20, 2025

Why Amylyx Pharmaceuticals Inc. stock attracts global investorsWeekly Trend Report & Daily Profit Focused Stock Screening - newser.com

Oct 20, 2025
pulisher
Oct 19, 2025

How the Class Action Investigation Into Relyvrio Disclosures at Amylyx Pharmaceuticals (AMLX) Has Changed Its Investment Story - Sahm

Oct 19, 2025
pulisher
Oct 19, 2025

How Amylyx Pharmaceuticals Inc. stock benefits from global expansionRecession Risk & Advanced Technical Signal Analysis - nchmf.gov.vn

Oct 19, 2025
pulisher
Oct 18, 2025

Is Amylyx Pharmaceuticals Inc. stock attractive for long term wealth buildingPortfolio Gains Summary & Reliable Price Breakout Alerts - newser.com

Oct 18, 2025
pulisher
Oct 18, 2025

How supply chain issues affect Amylyx Pharmaceuticals Inc. stockPortfolio Return Report & Scalable Portfolio Growth Methods - nchmf.gov.vn

Oct 18, 2025
pulisher
Oct 18, 2025

Growth Value: Why Amylyx Pharmaceuticals Inc. stock attracts global investorsBull Run & High Yield Equity Trading Tips - nchmf.gov.vn

Oct 18, 2025
pulisher
Oct 18, 2025

Is Amylyx Pharmaceuticals Inc. stock a top pick in earnings seasonInsider Buying & Expert Approved Momentum Ideas - nchmf.gov.vn

Oct 18, 2025
pulisher
Oct 18, 2025

Aug Swings: Is Amylyx Pharmaceuticals Inc. stock a top pick in earnings seasonQuarterly Trade Summary & Low Risk Profit Maximizing Plans - nchmf.gov.vn

Oct 18, 2025
pulisher
Oct 17, 2025

Volatility Watch: Will Amylyx Pharmaceuticals Inc. stock beat EPS estimates2025 Technical Overview & Free Real-Time Market Sentiment Alerts - nchmf.gov.vn

Oct 17, 2025
pulisher
Oct 17, 2025

Amylyx Pharmaceuticals (AMLX): Assessing Valuation After Class Action Probe Challenges Relyvrio Demand Claims - Sahm

Oct 17, 2025
pulisher
Oct 17, 2025

Will Amylyx Pharmaceuticals Inc. stock beat EPS estimatesShort Setup & Weekly Top Performers Watchlists - nchmf.gov.vn

Oct 17, 2025
pulisher
Oct 17, 2025

Exit Recap: Is Amylyx Pharmaceuticals Inc. stock affected by interest rate hikesGold Moves & Expert Curated Trade Setups - nchmf.gov.vn

Oct 17, 2025
pulisher
Oct 17, 2025

Important Notice to Long-Term Shareholders of Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX); ... - Bluefield Daily Telegraph

Oct 17, 2025
pulisher
Oct 17, 2025

Oklahoma City NewsThe Oklahoman - FinancialContent

Oct 17, 2025
pulisher
Oct 16, 2025

Is AMLX Stock a Solid Choice Right Now? - sharewise.com

Oct 16, 2025
pulisher
Oct 16, 2025

AMYLYX INVESTIGATION: Bragar Eagel & Squire, P.C. Urges - GlobeNewswire

Oct 16, 2025
pulisher
Oct 16, 2025

About Us - FinancialContent

Oct 16, 2025
pulisher
Oct 16, 2025

Baird Maintains Amylyx Pharmaceuticals (AMLX) Outperform Recommendation - Nasdaq

Oct 16, 2025
pulisher
Oct 15, 2025

How institutional ownership impacts Amylyx Pharmaceuticals Inc. stockWeekly Trend Recap & Technical Pattern Based Signals - newser.com

Oct 15, 2025
pulisher
Oct 14, 2025

Amylyx Pharmaceuticals prices $175M public offering - MSN

Oct 14, 2025
pulisher
Oct 14, 2025

Attention Long-Term Shareholders of Amylyx Pharmaceuticals, - GlobeNewswire

Oct 14, 2025
pulisher
Oct 14, 2025

Will Amylyx Pharmaceuticals Inc. stock continue upward momentumMarket Volume Report & Daily Entry Point Trade Alerts - newser.com

Oct 14, 2025
pulisher
Oct 13, 2025

Amylyx Pharmaceuticals, Inc. Securities Lawsuit Investigation - Claim Depot

Oct 13, 2025
pulisher
Oct 13, 2025

Published on: 2025-10-13 09:41:01 - newser.com

Oct 13, 2025
pulisher
Oct 13, 2025

Amylyx Pharmaceuticals Q2 2025 Earnings Preview - MSN

Oct 13, 2025
pulisher
Oct 13, 2025

Upcoming Events - FinancialContent

Oct 13, 2025

Amylyx Pharmaceuticals Inc (AMLX) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$37.48
price up icon 2.32%
$87.30
price up icon 1.31%
$30.13
price down icon 1.34%
$106.89
price down icon 0.98%
biotechnology ONC
$315.74
price down icon 0.90%
$165.31
price down icon 1.55%
大文字化:     |  ボリューム (24 時間):